| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Operating Officer
1 company
Kling Douglas F is a Chief Operating Officer at NewAmsterdam Pharma Co N.V.. Recent SEC Form 4 filings include 0 buys and 19 sells.
Estimated insider holdings value: $3.7M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jul 16, 2025 | NAMS Newamsterdam Pharma Co N.V. | Chief Operating Officer | Sale+OE | 98,612 | $21.26 | $2,096,655.08 | -42.1% | +81.0% | - | |
| Jun 16, 2025 | NAMS Newamsterdam Pharma Co N.V. | Chief Operating Officer | Sale+OE | 100,000 | $19.29 | $1,929,141.04 | -48.5% | +22.1% | - | |
| May 15, 2025 | NAMS Newamsterdam Pharma Co N.V. | Chief Operating Officer | Sale+OE | 100,000 | $0.00 | - | -69.4% | +37.8% | - | |
| Apr 15, 2025 | NAMS Newamsterdam Pharma Co N.V. | Chief Operating Officer | Sale+OE | 100,000 | $0.00 | - | -52.9% | +38.0% | +116.4% | |
| Mar 26, 2025 | NAMS Newamsterdam Pharma Co N.V. | Chief Operating Officer | Sale+OE | 16,539 | $0.00 | - | -27.3% | -18.4% | +38.5% | |
| Mar 17, 2025 | NAMS Newamsterdam Pharma Co N.V. | Chief Operating Officer | Sale+OE | 100,000 | $0.00 | - | -69.4% | -15.4% | +31.1% | |
| Feb 19, 2025 | NAMS Newamsterdam Pharma Co N.V. | Chief Operating Officer | Sale+OE | 100,000 | $0.00 | - | -53.2% | +1.2% | +81.1% | |
| Jan 30, 2025 | NAMS Newamsterdam Pharma Co N.V. | Chief Operating Officer | Sale+OE | 70,441 | $0.00 | - | -33.3% | -12.1% | +42.9% | |
| Jan 28, 2025 | NAMS Newamsterdam Pharma Co N.V. | Chief Operating Officer | Sale+OE | 129,559 | $0.00 | - | -38.7% | -16.9% | +48.6% |